Skip to main content
VulnerabilityPublished

CVE-2026-18196: IBM App Connect Enterprise · Cross-site Scripting

Affects IBM App Connect EnterpriseSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 5.4 Medium.

Data as of 8 Nov 2026, 18:04 UTC

CVSS 3.1 base score
5.4Medium
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ibm)CVSS 3.15.4
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 8 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 8 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
IBMApp Connect EnterpriseAffected
  • >=13.0.1.0 <=13.0.8.2
  • >=12.0.1.0 <=12.0.12.30
Fixed in–

CPE configurations (4)

  • cpe:2.3:a:ibm:app_connect_enterprise:13.0.1.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:app_connect_enterprise:12.0.1.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:app_connect_enterprise:13.0.8.2:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:app_connect_enterprise:12.0.12.30:*:*:*:*:*:*:*

AI-suggested

Until a fix is applied, users should be cautious with untrusted input and consider applying any available updates or workarounds from IBM.

Description

CVE-2026-18196 is a medium severity cross-site scripting (XSS) vulnerability in IBM App Connect Enterprise versions 13.0.1.0 through 13.0.8.2 and 12.0.1.0 through 12.0.12.30. It allows a remote attacker to inject arbitrary HTML due to improper output neutralization. The vulnerability requires user interaction (UI:R) and does not require privileges (PR:N).

References

Community reviews

Loading reviews…